Brain Tumors in Pediatric Patients
DOI:
https://doi.org/10.22376/ijtos.2024.2.3.14-22Keywords:
Pediatric brain tumors, Astrocytomas, Medulloblastomas, Choroid plexus tumors, Treatment strategies, Long-term outcomesAbstract
Pediatric brain tumors are the most common solid tumors in children, comprising a diverse group of neoplasms that vary in histology, location, and behavior. Common types include astrocytomas, medulloblastomas, ependymomas, and brainstem gliomas. Symptoms often depend on the tumor's location and may include headaches, nausea, vomiting, balance issues, and cognitive or behavioral changes. Advances in imaging, surgical techniques, and therapies, including radiation and chemotherapy, have improved outcomes. However, treatment can have long-term effects on cognitive and physical development, making comprehensive care and follow-up essential for pediatric patients. Early published reviews on pediatric brain tumors may have several lacunae, such as limited data on long-term outcomes, emerging treatment modalities, and the genetic and molecular underpinnings of various tumor types. They might also inadequately address the psychosocial impacts on patients and families. Therefore, a comprehensive review is needed to synthesize the latest research on pediatric brain tumors, encompassing advancements in diagnosis, treatment, and survivorship care. This updated review will provide valuable insights for clinicians, researchers, and policymakers to improve managing and supporting children with brain tumors. The review covers various aspects of pediatric brain tumors, focusing on choroid plexus tumors and spinal cord tumors. It discusses treatment strategies, highlighting surgical, radiotherapy, and chemotherapy options. The review also details presenting signs and symptoms of brain tumors in children, such as headaches, nausea, vomiting, balance issues, and changes in behavior or cognition. These insights aim to enhance early diagnosis and effective management, improving outcomes for affected children. This review addresses gaps in earlier studies on pediatric brain tumors by providing comprehensive insights into choroid plexus and spinal cord tumors, updated treatment strategies, and detailed symptoms. It synthesizes recent research to enhance early diagnosis and management, meeting current needs for effective, tailored treatment and improving patient outcomes.
References
Ostrom QT, Gittleman H, Xu J, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013. Neuro Oncol 2016;18(suppl_5):v1–75.
Deorah S, Lynch CF, Sibenaller ZA, Ryken TC. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurgical focus. 2006 Apr 1;20(4):E1.
Zhang J, Walsh MF, Wu G, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med 2015;373(24):2336–46.
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114(2): 97Y109. doi:10.1007/s00401-007-0243-4
Gurney J, Smith M, Bunin G. CNS and miscellaneous intracranial and intraspinal neoplasms. In: Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. NIH Publication No. 99-4649. In: Ries L, smith M, Gurney J, editors. National Cancer Institute SEER Program. Bethesda (MD): NIH Publication; 1999. p. 51–63.
Poussaint TY. Pediatric brain tumors. In: Newton HB, Jolesz FA, editors. Handbook of neuro-oncology neuroimaging. New York: Elsevier; 2008. p. 469–84
Tong Z, Yamaki T, Harada K, et al. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging 2004; 22:1017–24.
Hwang JH, Egnaczyk GF, Ballard E, et al. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 1998; 19:535–40.
Barkovich AJ, Raybaud C. Intracranial, orbital and neck masses of childhood. In: Pediatric Neuroimaging. 5th edition. Philadelphia: Lippincott Williams & Wilkins and Wolters Kluwer; 2012. p. 637–711.
Schneider JF, Gouny C, Viola A, et al. Multiparametric differentiation of posterior fossa tumors in children using diffusion-weighted imaging and short echo-time 1H-MR spectroscopy. J Magn Reson Imaging 2007;26:1390–8
Panigrahy A, Nelson M, Blu´ml S. Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol 2010;40:3–30
Pollack IF, Jakacki RI. Childhood brain tumors: epidemiology, current management and future directions. Nat Rev Neurol 2011;7:495–506.
Pfister S, Hartmann C, Korshunov A. Histology and molecular pathology of pediatric brain tumors. J Child Neurol 2009;24:1375–86.
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131:803–20
Ostrom QT, Price M, Ryan K, Edelson J, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro-oncology. 2022 Sep 2;24(Supplement_3):iii1-38.
Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, et al. Alex’s lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 2015;16:x1–x36.
Taylor MD, Mainprize TG, Rutka JT. Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review. Neurosurgery 2000;47:888–901.
Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233–8.
Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16: 64–7.
Kleihues P, Cavanee WK, editors. Pathology and genetics of tumours of the nervous system. World Health Organization classification of tumours. Lyon, France: IARC Press; 2000.
Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002;415:436–42
Rickert CH, Paulus W. Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst 2001;17:503–11
Kumar L, Deepa SF, Moinca I, Suresh P, Naidu KR. Medulloblastoma: A common pediatric tumor: Prognostic factors and predictors of outcome. Asian Journal of Neurosurgery. 2015 Mar;10(01):50-.
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114(2): 97Y109. doi:10.1007/s00401-007-0243-4.
Delion M, Dinomais M, Mercier P. Arteries and veins of the cerebellum. The Cerebellum. 2017 Dec;16(5):880-912.
Albright AL, Sposto R, Holmes E, et al. Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors. Neurosurgery 2000;47(4):879–85 [discussion: 885–7].
Robertson PL, Muraszko KM, Holmes EJ, et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children’s Oncology Group. J Neurosurg 2006;105(6 Suppl):444–51.
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109.
Debarati, J. and Koteswara Reddy, G., Hari Sai Ram A, Hyacinthe Tuyubahe, Allam Ganesh, Vempati Gopi Krishna and Janaki Ramaiah Mekala, New Therapeutic Compounds and Recent Advancements in Metastasis Cancer Treatment: A Review.(2023). Int. J. Life Sci. Pharma Res, 13(6), pp.L132-L143.
Dhall G, Grodman H, Ji L, et al. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the Head Start I and II protocols. Pediatr Blood Cancer 2008;50:1169–75.
Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978–86.
Rutkowski S, Cohen B, Finlay J, et al. Medulloblastoma in young children. Pediatr Blood Cancer 2010;54:635–7.
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131:803–20
Lupatsch JE, Bailey HD, Lacour B, Dufour C, Bertozzi AI, Leblond P, et al. Childhood brain tumours, early infections and immune stimulation: a pooled analysis of the ESCALE and ESTELLE case-control studies (SFCE, France). Cancer Epidemiol 2018;52:1–9.
Andersen TV, Schmidt LS, Poulsen AH, Feychting M, Roosli M, Tynes T, et al. Patterns of exposure to infectious diseases and social contacts in early life and risk of brain tumours in children and adolescents: an international case-control study (CEFALO). Br J Cancer 2013;108:2346–53
Louis DN, Ohgaki H, Wiestler OD, et al. WHO classification of tumours of the central nervous system, revised. 4th edition. World Health Organization; 2016.
Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002; 415(6870):436–42.
Perez-Martinez A, Lassaletta A, Gonzalez-Vicent M, et al. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol 2005;71(1):33–8.
Friedrich C, von Bueren AO, von Hoff K, et al. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol 2013;15(2):224–34.
Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children’s Cancer Group. J Clin Oncol 2005;23(30):7621–31.
Rorke LB, Packer R, Biegel J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol 1995; 24(1):21Y28.
Biegel JA. Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus 2006;20(1):E11.
Ginn KF, Gajjar A. Atypical teratoid rhabdoid tumor: current therapy and future directions. Front Oncol 2012;2:114.
Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59(1):74–9.
Hasselblatt M, Nagel I, Oyen F, et al. SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis. Acta Neuropathol 2014;128(3):453–6.
Eaton KW, Tooke LS, Wainwright LM, et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 2011; 56(1):7–15.
Johann PD, Erkek S, Zapatka M, et al. Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 2016;29(3):379–93.
Wetmore C, Boyett J, Li S, et al. Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children. Neuro Oncol 2015;17(6):882–8.
Allen JC, Siffert J, Hukin J. Clinical manifestations of childhood ependymoma: a multitude of syndromes. Pediatr Neurosurg 1998;28(1):49–55.
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114(2):97–109
Kilday JP, Rahman R, Dyer S, et al. Pediatric ependymoma: biological perspectives. Mol Cancer Res 2009;7(6):765–86.
Garre ML, Cama A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr 2007;19(4):471–9.
Manoj L, Kalyani M, Jyothi K, Bhavani GG, Govardhani V, Srinivasan R. Review of brain and brain cancer treatment. International Journal of Pharma and Bio Sciences. 2011;2:468-77.
Hoffmann A, Boekhoff S, Gebhardt U, et al. History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis. Eur J Endocrinol 2015;173(6):853–62.
Rucka E, Wedrychowicz A, Zygmunt-Gorska A, et al. Clinical symptoms at the diagnosis of the craniopharyngioma. Pediatr Endocrinol Diabetes Metab 2012;18(2):58–62
Garnett MR, Puget S, Grill J, et al. Craniopharyngioma. Orphanet J Rare Dis 2007;2:18
Sartoretti-Schefer S, Wichmann W, Aguzzi A, et al. MR differentiation of adamantinous and squamous-papillary craniopharyngiomas. AJNR Am J Neuroradiol 1997;18(1):77–87.
Gozali AE, Britt B, Shane L, et al. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children’s Hospital Los Angeles (CHLA) experience, 1991-2010. Pediatr Blood Cancer 2012; 58(6):905–9.
Koeller KK, Sandberg GD. From the archives of the AFIP. Cerebral intraventricular neoplasms: radiologic-pathologic correlation. Radiographics 2002;22(6): 1473–505.
Rostasy KM, Sponholz S, Bahn E, et al. Unusual localization of a choroid plexus papilloma in a 4-year-old female. Pediatr Neurol 2003;28(1):66–8.
Tabori U, Shlien A, Baskin B, et al. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol 2010;28(12): 1995–2001.
Hayden Gephart MG, Lober RM, Arrigo RT, et al. Trends in the diagnosis and treatment of pediatric primary spinal cord tumors. J Neurosurg Pediatr 2012; 10(6):555–9
DeSousa AL, Kalsbeck JE, Mealey J Jr, et al. Intraspinal tumors in children. a review of 81 cases. J Neurosurg 1979;51(4):437–45.
Crawford JR, Zaninovic A, Santi M, et al. Primary spinal cord tumors of childhood: effects of clinical presentation, radiographic features, and pathology on survival. J Neurooncol 2009;95(2):259–69.
Epstein F, Epstein N. Surgical treatment of spinal cord astrocytomas of childhood. A series of 19 patients. J Neurosurg 1982;57(5):685–9.
Jallo GI, Freed D, Epstein F. Intramedullary spinal cord tumors in children. Childs Nerv Syst 2003;19(9):641–9.
Merchant TE, Kiehna EN, Thompson SJ, et al. Pediatric low-grade and ependymal spinal cord tumors. Pediatr Neurosurg 2000;32(1):30–6.
Crawford J. Childhood brain tumors. Pediatr Rev 2013;34: 63–78.
Gajjar A, Bowers DC, Karajannis MA, Leary S, Witt H, Gottardo NG. Pediatric brain tumors: innovative genomic information is transforming the diagnostic and clinical landscape. J Clin Oncol 2015;33:2986–98.
Wells EM, Packer RJ. Pediatric brain tumors. Continuum 2015;21:373–96.
Dhall G, Grodman H, Ji L, et al. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the Head Start I and II protocols. Pediatr Blood Cancer 2008;50:1169–75.
Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978–86.
Rutkowski S, Cohen B, Finlay J, et al. Medulloblastoma in young children. Pediatr Blood Cancer 2010;54:635–7
Morfouace M, Shelat A, Jacus M, et al. Pemetrexed and gemcitabine as combination therapy for the treatment of Group 3 medulloblastoma. Cancer Cell 2014;25:516–29
Published
How to Cite
Issue
Section
Copyright (c) 2024 Dr. Kumud Kumari
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
